Reply to Manthey et al .: Estimating the association between THC and health outcomes requires rigorous research methods and continued monitoring of cannabis markets
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Challenges in establishing a link between THC exposure and cannabis use disorderAddiction, 2026
- Estimating thresholds for risk of cannabis use disorder using standard delta‐9‐tetrahydrocannabinol (THC) unitsAddiction, 2026
- Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumersAddiction, 2024
- Enhanced cannabis timeline followback (EC‐TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measuresAddiction, 2023
- The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controlsJournal of Psychopharmacology, 2022
- Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations updateInternational Journal of Drug Policy, 2022
- Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment ratesThe Lancet Regional Health - Europe, 2021
- Potency of Δ9–tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacologyDrug Testing and Analysis, 2018